CD8A and neoplasm: We have also previously shown significant renewal of OVA/gp100/Trp2 specific CD8+ T cells in the peripheral lymphoid tissues of B16-OVA tumor-bearing mice, which was again most evident in the ICI plus virus treatment group (21).